YOUR JOURNEY: OPTIMIZING THE VALUE OF YOUR COMPOUND
First seminar: THE BASIC STEPS: Getting ready for a development plan
Meet with PAREXEL, Berlin Cures and High-Tech Gründerfonds Management GmbH to hear industry experts discuss topics related to YOUR JOURNEY: Optimizing the value of your compound.
Featured speakers:
Anders Neil, Principal Consultant, PAREXEL
Niels-Peter Becker, Manager Scientific and Regulatory Affairs, Berlin Cures GmbH
Alex Gee, Principal Pricing and Access Consultant, PAREXEL
Frank Hensel, Principal, High-Tech Gründerfonds Management GmbH
Martin Pfister, Sr Investment Manager, High-Tech Gründerfonds Management GmbH
Agenda:
Time
Title
Speaker
Checking-In: The basic steps: Getting ready for a development plan
9:30 - 10:00
Welcome coffee and registration
10:00 - 10:10
Introduction
Are you ready for the journey?
10:10 - 10:50
Due Diligence: regulatory requirements
& data needed for clinical development
Anders Neil, Principal Consultant, PAREXEL
10:50 - 11:30
BC 007 with high speed to clinical development – The start-up perspective
Niels-Peter Becker, Manager Scientific and Regulatory Affairs, Berlin Cures GmbH
11:30 - 11:45
Coffee break
Will your journey pay off?
11:45 - 12:25
The importance of defining early commercial and market value for your product
Alex Gee, Principal Pricing and Access Consultant, PAREXEL
12:25 - 13:00
Lunch
13:00 - 14:20
VC backed biotech companies – an investor’s look
at developing therapy targets in a start-up biotech
13:00 - 13:40
a) Biologicals – CMC and other challenges
Frank Hensel, Principal, High-Tech Gründerfonds Management GmbH
13:40 - 14:20
b) Small molecules – just ticking boxes?
Martin Pfister, Sr Investment Manager, High-Tech Gründerfonds Management GmbH
14:20 - 14:30
Closing remarks
Would you like to hear from us in the future?
Note: You will be registered for this event and receive event-related emails regardless of your selection.
Please select any one option.
Yes, I would like to receive marketing communications including industry insights and trends from PAREXEL International.